// App-Quantinova.ai

: REAL-WORLD TREATMENT PATTERNS AMONG PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) TREATED WITH CD19-DIRECTED CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY (CAR T)

Researchers

Presenter

  • Jessica J Jalbert

Principal Investigators

  • Jon E Arnason

  • Wenzhen Ge

  • Chieh-I Chen

  • Srikanth Ambati

  • Ning Wu

  • Aafia Chaudhry

Medical Centers

  • Regeneron Pharmaceuticals, Inc., Tarrytown, NY, United States.

  • Beth Israel Deaconess Medical Center, Medicine, Boston, MA, United States

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Diffuse large B-cell lymphoma

  • Acute lymphoblastic leukemia

  • B cell lymphomas

  • Lymphomas

Biomarkers

  • Coxsackie Virus And Adenovirus Receptor

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved